{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T19:06:39Z","timestamp":1767467199051,"version":"3.48.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to determine the prevalence of elevated serum Immunoglobulin E (IgE) levels among adult patients with asthma and to investigate the association between IgE levels and hospital admissions, ICU admissions, asthma control, and other clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective single-centre study. Adult patients with a confirmed diagnosis of asthma between 28 February 2023 and 1 March 2024 at Al-Noor Specialist Hospital, Mecca, Saudi Arabia, were included. Patients were excluded if their records lacked spirometry or serum IgE data. Population characteristics were presented as frequency for categorical variables and median with interquartile range for continuous variables. Logistic regression analysis was used to identify predictors of severe asthma outcomes stratified by IgE levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 807 asthma patients, with a majority being females (68.9%) and a mean age of 48.2 years. A total of 311 patients (38.5%) had elevated serum IgE levels (&gt;\u2009100 IU). Patients with high IgE levels had significantly higher rates of hospital admission due to asthma (16.4% vs. 7.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and ICU admission (4.2% vs. 1.2%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008). They were also less likely to have controlled asthma (42.4% vs. 78.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and more likely to report frequent acute care service visits (62.1% vs. 32.5%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Logistic regression showed that elevated IgE levels were significantly associated with increased odds of hospital admission (OR\u2009=\u20092.6, 95% CI = [1.6\u20134.0],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), ICU admission (OR\u2009=\u20093.5, 95% CI = [1.3\u20139.4],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011), uncontrolled asthma (OR\u2009=\u20090.2, 95% CI = [0.1\u20130.3],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and frequent ACS visits (OR\u2009=\u20090.3, 95% CI = [0.2\u20130.4],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated serum IgE levels are significantly associated with poorer asthma control, increased hospital admissions, and higher ICU admission rates. Stratifying asthma patients based on IgE levels may help identify high-risk individuals and guide management strategies through a targeted approach.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-025-01003-z","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:49:42Z","timestamp":1764334182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and association of elevated total serum IgE levels with ICU admissions and poor asthma control: a retrospective study in a tertiary hospital in Saudi Arabia"],"prefix":"10.1186","volume":"22","author":[{"given":"Hassan","family":"Alwafi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husna Irfan","family":"Thalib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safaa M.","family":"Alsanosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah Y.","family":"Naser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulelah M.","family":"Aldhahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah A.","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaber S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed M.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Saleh","family":"Dairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omaima Ibrahim","family":"Badr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"1003_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fped.2019.00068","volume":"7","author":"A Bush","year":"2019","unstructured":"Bush A. Pathophysiological mechanisms of asthma. Front Pediatr. 2019;7:68. https:\/\/doi.org\/10.3389\/fped.2019.00068.","journal-title":"Front Pediatr"},{"issue":"1","key":"1003_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12890-023-02342-6","volume":"23","author":"H Alwafi","year":"2023","unstructured":"Alwafi H, Naser AY, Ashoor DS, Aldhahir AM, Alqahtani JS, Minshawi F, Salawati E, Samannodi M, Dairi MS, Alansari AK, Ekram R. Trends in hospital admissions and prescribing due to chronic obstructive pulmonary disease and asthma in England and Wales between 1999 and 2020: an ecological study. BMC Pulm Med. 2023;23(1):49. https:\/\/doi.org\/10.1186\/s12890-023-02342-6.","journal-title":"BMC Pulm Med"},{"key":"1003_CR3","doi-asserted-by":"publisher","unstructured":"Haya Tabaza RA, Farha, Abdallah Y, Naser O, Awwad. Treatment-related problems and their cost among patients hospitalised with asthma exacerbation. J Pharm Health Serv Res. 2023;14(3):359\u201366. https:\/\/doi.org\/10.1093\/jphsr\/rmad027.","DOI":"10.1093\/jphsr\/rmad027"},{"issue":"3","key":"1003_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.anai.2015.10.026","volume":"116","author":"BT Kelly","year":"2016","unstructured":"Kelly BT, Grayson MH, Immunoglobulin E. What is it good for? Ann Allergy Asthma Immunol. 2016;116(3):183\u20137. https:\/\/doi.org\/10.1016\/j.anai.2015.10.026.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"1003_CR5","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.4049\/jimmunol.1601476","volume":"197","author":"T Kawakami","year":"2016","unstructured":"Kawakami T, Blank U. From IgE to Omalizumab. J Immunol. 2016;197(11):4187\u201392. https:\/\/doi.org\/10.4049\/jimmunol.1601476.","journal-title":"J Immunol"},{"issue":"2","key":"1003_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.15537\/smj.2018.2.20974","volume":"39","author":"MO Al Ghobain","year":"2018","unstructured":"Al Ghobain MO, Algazlan SS, Oreibi TM. Asthma prevalence among adults in Saudi Arabia. Saudi Med J. 2018;39(2):179\u201384. https:\/\/doi.org\/10.15537\/smj.2018.2.20974.","journal-title":"Saudi Med J"},{"issue":"9","key":"1003_CR7","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/jcm8091283","volume":"8","author":"E Kostakou","year":"2019","unstructured":"Kostakou E, Kaniaris E, Filiou E, Vasileiadis I, Katsaounou P, Tzortzaki E, Koulouris N, Koutsoukou A, Rovina N. Acute severe asthma in adolescent and adult patients: current perspectives on assessment and management. J Clin Med. 2019;8(9):1283. https:\/\/doi.org\/10.3390\/jcm8091283.","journal-title":"J Clin Med"},{"issue":"3","key":"1003_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/0970-2113.68312","volume":"27","author":"T Sandeep","year":"2010","unstructured":"Sandeep T, Roopakala MS, Silvia CR, Chandrashekara S, Rao M. Evaluation of serum Immunoglobulin E levels in bronchial asthma. Lung India. 2010;27(3):138\u201340. https:\/\/doi.org\/10.4103\/0970-2113.68312.","journal-title":"Lung India"},{"key":"1003_CR9","doi-asserted-by":"publisher","unstructured":"Aziz DA, Bajwa RA, Omar M, Viquar W. Immunoglobulin Ige levels and clinical dynamics of asthma in children and adolescents. J Ayub Med Coll Abbottabad. 2023;35(1):S752\u20136. https:\/\/doi.org\/10.55519\/JAMC-S4-12394.","DOI":"10.55519\/JAMC-S4-12394"},{"key":"1003_CR10","doi-asserted-by":"publisher","unstructured":"Al-Moamary MS, Alhaider SA, Alangari AA, Idrees MM, Zeitouni MO, Al Ghobain MO, Alanazi AF, Al-Harbi AS, Yousef AA, Alorainy HS, Al-Hajjaj MS. The Saudi initiative for asthma \u2013\u20092021 update: guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med. 2021;16(1):4\u201356. https:\/\/doi.org\/10.4103\/atm.ATM_697_20.","DOI":"10.4103\/atm.ATM_697_20"},{"issue":"1","key":"1003_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-023-02775-z","volume":"23","author":"AY Naser","year":"2023","unstructured":"Naser AY, Dairi MS, Alwafi H, Ashoor DS, Qadus S, Aldhahir AM, et al. The rate of ward to intensive care transfer and its predictors among hospitalized COPD patients, a retrospective study in a local tertiary center in Saudi Arabia. BMC Pulm Med. 2023;23(1):1\u201314.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"1003_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","volume":"113","author":"RA Nathan","year":"2004","unstructured":"Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59\u201365. https:\/\/doi.org\/10.1016\/j.jaci.2003.09.008.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1003_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/0009922819887399","volume":"59","author":"P James","year":"2020","unstructured":"James P, Cornish A, Brady K, Morrison J, Giunta Y, Zuckerman B, Hahn B. Is there benefit in identifying asthma triggers during an exacerbation? Clin Pediatr (Phila). 2020;59(2):142\u20137. https:\/\/doi.org\/10.1177\/0009922819887399.","journal-title":"Clin Pediatr (Phila)"},{"key":"1003_CR14","doi-asserted-by":"publisher","unstructured":"Sherenian MG, Wang Y, Fulkerson PC. Hospital admission associates with higher total IgE level in pediatric patients with asthma. J Allergy Clin Immunol Pract. 2015;3(4):602\u2013e31. https:\/\/doi.org\/10.1016\/j.jaip.2015.01.014.","DOI":"10.1016\/j.jaip.2015.01.014"},{"key":"1003_CR15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s12325-019-01191-2","volume":"37","author":"DJ Jackson","year":"2020","unstructured":"Jackson DJ, Humbert M, Hirsch I, Newbold P, Garcia Gil E. Ability of serum IgE concentration to predict exacerbation risk and benralizumab efficacy for patients with severe eosinophilic asthma. Adv Therapy. 2020;37:718\u201329.","journal-title":"Adv Therapy"},{"issue":"4","key":"1003_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/antib12040070","volume":"12","author":"P Kostova","year":"2023","unstructured":"Kostova P, Papochieva V, Miteva D, Georgieva B, Mileva S, Shahid M, Lukanov T, Petrova G. Elevated IgE Levels-An allergy or an underlying inborn error of immunity in children with recurrent infections? Antibodies (Basel). 2023;12(4):70. https:\/\/doi.org\/10.3390\/antib12040070.","journal-title":"Antibodies (Basel)"},{"key":"1003_CR17","doi-asserted-by":"publisher","unstructured":"Iordache A, Balica NC, Horhat ID, Morar R, Tischer AA, Milcu AI, Salavat MC, Borug\u0103 VM. A review regarding the connections between allergic rhinitis and Asthma - epidemiology, diagnosis and treatment. Curr Health Sci J 2023;49(1):5\u201318. https:\/\/doi.org\/10.12865\/CHSJ.49.01.5","DOI":"10.12865\/CHSJ.49.01.5"},{"key":"1003_CR18","doi-asserted-by":"publisher","unstructured":"Pelaia C, Calabrese C, Terracciano R, de Blasio F, Vatrella A, Pelaia G. Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness. Ther Adv Respir Dis. 2018;12:1753466618810192. https:\/\/doi.org\/10.1177\/1753466618810192.","DOI":"10.1177\/1753466618810192"},{"issue":"8","key":"1003_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1080\/09593985.2017.1331479","volume":"33","author":"E Grammatopoulou","year":"2017","unstructured":"Grammatopoulou E, Pt PhD, Skordilis EK, PhD, Haniotou A, Md Fccp JZ, MSc, Athanasopoulos S, Pt PhD. The effect of a holistic self-management plan on asthma control. Physiother Theory Pract. 2017;33(8):622\u201333. https:\/\/doi.org\/10.1080\/09593985.2017.1331479.","journal-title":"Physiother Theory Pract"},{"key":"1003_CR20","doi-asserted-by":"publisher","first-page":"839011","DOI":"10.3389\/fphar.2022.839011","volume":"13","author":"Y Gon","year":"2022","unstructured":"Gon Y, Maruoka S, Mizumura K. Omalizumab and IgE in the control of severe allergic asthma. Front Pharmacol. 2022;13:839011.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1003_CR21","doi-asserted-by":"publisher","first-page":"CD003559","DOI":"10.1002\/14651858.CD003559.pub4","volume":"2014","author":"R Normansell","year":"2014","unstructured":"Normansell R, Walker S, Milan SJ, Walters EH, Nair P. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;2014(1):CD003559. https:\/\/doi.org\/10.1002\/14651858.CD003559.pub4.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-01003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-025-01003-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-01003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T19:04:58Z","timestamp":1767467098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13223-025-01003-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1003"],"URL":"https:\/\/doi.org\/10.1186\/s13223-025-01003-z","relation":{},"ISSN":["1710-1492"],"issn-type":[{"type":"electronic","value":"1710-1492"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional ethics board at the Ministry of Health in Saudi Arabia (IRB No. H-02-K-076\u20130523\u2013951). Due to the retrospective nature of the study, the requirement for written informed consent was waived. All procedures were conducted in accordance with the Declaration of Helsinki and local regulatory guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}